February 12, 2015 – Symphony Health Solutions (SHS) and the American College of Cardiology announced the completion of a ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
February 4, 2015 — Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it ...
February 04, 2015
January 22, 2015 — AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more ...
January 22, 2015
January 21, 2015 — A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in ...
January 21, 2015The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
January 21, 2015
January 14, 2015 — More than 10 percent of patients treated with aspirin therapy for primary cardiovascular disease ...
January 14, 2015
January 12, 2015 — Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 13, 2015January 7, 2015 — Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists ...
January 07, 2015
December 30, 2014 — Wearable technologies, possible changes to stenting practices, state legislation on energy drinks ...
December 30, 2014December 23, 2014 — The most accessed research studies in the Journal of the American College of Cardiology (JACC) in ...
December 23, 2014
December 16, 2014 — Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio ...
December 16, 2014
November 25, 2014 — Between 70 and 80 percent of patients with the connective tissue condition Marfan syndrome have ...
November 25, 2014
November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...
November 24, 2014
November 18, 2014 — Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary ...
November 18, 2014November 12, 2014 — The actions — or inaction — of patients should be considered in programs designed to improve care ...
November 12, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now